U.S. Medical Equipment Stock News

The Trump administration previously announced a voluntary investment consortium targeting up to US$4.00 trillion for semiconductor, energy, and critical minerals supply chains, with an initial US$250.00 million government contribution to support AI and chipmaking capabilities across the U.S. and allied nations. This initiative highlights how policy-driven capital could reinforce the ecosystem around materials suppliers like Entegris, which enable advanced semiconductor manufacturing. We’ll...

In recent days, Medtronic plc received U.S. FDA approval to expand use of its OmniaSecure defibrillation lead to the left bundle branch area and also entered a distribution agreement with Merit Medical Systems to offer the FDA-cleared ViaVerte basivertebral nerve ablation system for minimally invasive outpatient back pain treatment later this year. Together, these moves highlight Medtronic’s push to broaden its cardiac and pain therapy portfolios with specialized devices that could deepen...

Why Liberty Live Holdings is on investors’ radar Liberty Live Holdings (LLYV.K) has drawn attention after recent share price moves, with the stock showing mixed short term performance and a stronger total return over the past year. See our latest analysis for Liberty Live Holdings. The recent 1-day share price return of 1.47% takes Liberty Live Holdings to $94.99, while a 90-day share price return of 12.31% and 1-year total shareholder return of 37.37% indicate momentum building over the...

EnerSys (ENS) is reshaping its manufacturing footprint after announcing plans to close its legacy lead-acid battery plant in Tijuana, Mexico, and concentrate production at its TPPL facility in Springfield, Missouri. See our latest analysis for EnerSys. The restructuring news has arrived after a period of strong momentum, with the share price at US$177.42 and a 90-day share price return of 18.46%. The 1-year total shareholder return sits at 85.59%, pointing to investors reassessing both growth...

If you are wondering whether Doximity at around US$24.18 still reflects its underlying worth, the recent share performance gives you plenty to think about. The stock has been choppy, with a 2.5% decline over the last 7 days, a 1.8% gain over the last 30 days, and much steeper moves over longer periods, including a 44.1% decline year to date and a 60.7% decline over the last year. Against this backdrop, recent coverage has focused on how investors are reassessing digital health platforms and...

In March 2026, Zai Lab announced that three internally-developed oncology candidates, zocilurtatug pelitecan (zoci), ZL-6201, and ZL-1222, were presented across four poster sessions at the American Association for Cancer Research Annual Meeting 2026 in San Diego, highlighting progress in small cell lung cancer, sarcoma, and immuno-oncology programs. The company also outlined plans for three registration-enabling studies for zoci by the end of 2026, signaling its intent to position this...

Earlier this year, Corcept Therapeutics announced that the FDA approved Lifyorli (relacorilant) plus nab-paclitaxel for adults with previously treated platinum-resistant ovarian, fallopian tube, or primary peritoneal cancer, based on the ROSELLA trial’s dual primary endpoint success in progression-free and overall survival. This approval introduces the first selective glucocorticoid receptor antagonist in oncology care, highlighting cortisol signaling as a new treatment pathway in...

If you are wondering whether ADMA Biologics at around US$9.63 still offers value, or if most of the opportunity has already played out, this article breaks down what the current price might be implying. The stock has seen sharp moves recently, with a 35.2% decline over the last week, a 40.9% decline over the last month, a 46.1% decline year to date, and a 51.1% decline over the last year, even after a very large 3 year return and a 7x 5 year return. Recent coverage has focused on these...

Vail Resorts, Inc. recently outlined a multi-year plan to roll My Epic Gear features into its traditional rental outlets, adding premium equipment choices, digital booking, and flexible pick-up or delivery options across its resort network. By turning rentals into a personalized, app-driven service with specific model selection and archived gear preferences, Vail Resorts is effectively treating equipment as a repeatable, data-informed experience rather than a one-off transaction. Next, we’ll...

Earlier this week, sentiment toward Take-Two Interactive softened after major competitor Epic Games announced over 1,000 job cuts tied to lower Fortnite engagement and unsustainable spending, stoking worries about the broader video game market. At the same time, Take-Two’s inclusion as a top holding in JPMorgan’s actively managed U.S. Tech Leaders ETF highlights how some fund managers still view the company as an important player at the intersection of gaming and technology, including...

What recent returns say about Leggett & Platt (LEG) Leggett & Platt (LEG) has drawn fresh attention after a mixed stretch of performance, with a 0.4% decline over the past day, a 2.5% gain over the past week, and weaker month and past 3 months returns. In this context, investors are weighing how the current US$10.10 share price and the company’s value score of 5 line up with its recent revenue and net income figures as well as its longer term track record. See our latest analysis for Leggett...

If you are wondering whether Becton Dickinson's current share price reflects its true worth, you are not alone. Many investors are asking the same question right now. The stock last closed at US$158.27, with returns of 0.1% over 7 days, a 14.1% decline over 30 days, an 18.8% decline year to date, and a 9.6% decline over the past year, which may be changing how investors think about its risk and potential. Recent headlines around Becton Dickinson have kept attention on how the company is...

Halozyme Therapeutics, Inc. recently appointed David Ramsay as Interim Chief Financial Officer, effective March 23, 2026, tasking him with overseeing all financial operations while the company continues its search for a permanent CFO. Ramsay’s long history with Halozyme and deep capital markets experience may offer continuity and financial discipline at a time when the company is expanding its ENHANZE and related partnerships. Next, we’ll examine how Ramsay’s return as interim CFO could...

Signet Jewelers (NYSE:SIG) approved an almost 10% increase to its quarterly dividend, marking a fifth consecutive year of higher shareholder payouts. The company also recently completed another tranche of its ongoing share repurchase program. These twin capital return actions arrive at a time when other coverage of NYSE:SIG has centered on earnings results and valuation. Signet Jewelers, the owner of jewelry retail banners such as Kay, Zales, and Jared, sits at the intersection of...

Earlier this month, UiPath unveiled a wave of new agentic AI offerings for finance, retail, manufacturing, and financial services, while expanding CTO Raghu Malpani’s remit to Chief Product and Technology Officer and filing a US$356.70 million shelf registration tied to employee stock plans. Together, these releases and leadership changes highlight UiPath’s push to become an AI orchestration layer for complex enterprise workflows, embedding domain-specific agents across core operational...

M-tron Industries (MPTI) closed FY 2025 with fourth quarter revenue of US$14.2 million and basic EPS of US$1.16, alongside trailing twelve month revenue of US$54.4 million and EPS of US$2.94 that frame the latest print in a broader earnings context. Over the past six reported quarters, the company has seen quarterly revenue range from US$12.8 million to US$14.2 million and basic EPS move between US$0.55 and US$1.16, giving you a clear view of how the top line and EPS have tracked into this...

DXC Technology (DXC) has just earned a spot on Fortune's America's Most Innovative Companies list, reflecting its recent AI focused launches. Investors are weighing this recognition against ongoing concerns about sales trends and capital allocation. See our latest analysis for DXC Technology. DXC's recent recognition for its AI efforts comes after a mixed stretch for shareholders, with a 1-day share price return of 3.36% and 7-day share price return of 3.00% contrasting with a 1-year total...

Enterprise Products Partners (EPD) is back in the spotlight after Co CEO and Director Jim Teague presented at the World Chemical Forum 2026, alongside fresh bullish commentary from Jim Cramer on its midstream role. See our latest analysis for Enterprise Products Partners. The recent World Chemical Forum appearance and positive TV commentary come as Enterprise Products Partners records a 21.3% year to date share price return and a 23.4% 1 year total shareholder return, pointing to firm...

If you are wondering whether Monster Beverage is fairly priced or if the market is missing something, this article walks through the key numbers that matter for you as a shareholder or potential buyer. At a recent close of US$73.21, the stock has seen a 14.4% decline over the last 30 days, while the 1 year return stands at 25.0% and the 5 year return at 60.3%. Recent price moves have put more attention on what might be driving sentiment around Monster Beverage. Wider investor focus on large...

Charter Communications (NasdaqGS:CHTR) has partnered Spectrum Reach with DoubleVerify, making Spectrum Reach the first participant in DoubleVerify's Certified Transparent Streaming program. Spectrum News and Syracuse University's Newhouse School have formed a new partnership to provide students with hands-on experience across Spectrum News platforms. Charter has appointed John Lee as Head of Intelligence Ventures, a new team focused on intelligence-driven products and partnerships. For...

CubeSmart (CUBE) has been on investors’ radar after a recent stretch of mixed returns, highlighted by a roughly 9% decline over the past month alongside a modest gain in the past 3 months. See our latest analysis for CubeSmart. At a share price of US$36.20, CubeSmart’s recent 7 day and 30 day share price returns of roughly 6% and 9% declines contrast with a modestly positive year to date move and a 5 year total shareholder return of about 17%. This suggests momentum has softened even as...

Chewy (CHWY) has just put fresh numbers on the table for FY 2026, with Q3 revenue of US$3.1b and basic EPS of US$0.14, set against trailing 12 month revenue of US$12.6b and EPS of US$0.50. Over recent quarters the company has seen revenue move from US$2.9b in Q2 FY 2025 to US$3.1b in Q3 FY 2026. Over the same period, quarterly basic EPS has ranged from US$0.01 to US$0.70. This gives investors plenty to think about around the consistency of earnings and the pressure on margins. See our full...

On March 24, 2026, Robinhood Markets announced a new share repurchase program of up to US$1.50 billion in Class A common stock, to be carried out over roughly three years with no formal end date and supported by a US$3.25 billion credit facility. The buyback authorization, coming after a period of share price weakness and product mix shifts, highlights management’s preference for returning capital to shareholders while continuing to invest in crypto, prediction markets, and broader financial...

DouYu International Holdings (NasdaqGS:DOYU) has reported its FY 2025 third quarter results with revenue of C¥899.1 million and basic EPS of C¥0.38, while trailing 12 month figures point to revenue of about C¥4.0 billion and a basic EPS loss of C¥6.74. The company has seen recent quarterly revenue move between C¥947.1 million and C¥1.05 billion in FY 2025, with basic EPS swinging from a loss of C¥2.64 in the first quarter to a profit of C¥1.25 in the second quarter, before settling at C¥0.38...